InvestorsHub Logo

Valuator2

05/19/22 3:49 PM

#150999 RE: mineanddine #150994

That sounds more like financial advice than legal advice. So how would you be a position to know what the law firm advises and if you are, why would you release it?

bigtalan

05/19/22 4:04 PM

#151002 RE: mineanddine #150994

R/S still doesnt help and not needed. NASDAQ has requirements that even if they have a share price of 4.00 they would not meet.
https://www.sofi.com/learn/content/nasdaq-listing-requirements/ i know it is from 2021 they haven't changed GLTA

Dyno89

05/19/22 7:19 PM

#151014 RE: mineanddine #150994

Lmao “blown out”. I’ve posted verifiable share structure comparisons to other major pharmas numerous times. ENZC’s share structure is similar or BETTER to 75% or more of the top ones dozen I posted. That includes a handful of big pharma.

Otclawyers should stick to shilling on Twitter for otc clients and give less amateurish advice to companies on how to run their bio business.

Valuator2

05/20/22 12:11 AM

#151041 RE: mineanddine #150994

Thanks for the link. I watched the video and just as I thought, the lawyer did NOT reveal any advice he has given to any specific client, including ENZC. In fact, I thought his opinion about R/S as a means of uplifting was pretty low, which is my own view as well.